Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

Experimental Cell Research

Volumn 305, Issue 1, 2005, Pages 33-41

  Rasmusson, Ida ^a   Ringdén, Olle ^a   Sundberg, Berit ^a   Le Blanc, Katarina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Marrow stromal cells; Mixed lymphocyte cultures; Prostaglandin

Indexed keywords

ALLOANTIGEN; CYTOKINE; INDOMETACIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTICLE; BLOOD LEVEL; BONE MARROW CELL; CELL FUNCTION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NORMAL HUMAN; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE;

EID: 15044348816     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.12.013     Document Type: Article

References (37)

1. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, P. Matteucci, S. Grisanti, and A.M. Gianni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843
2. W.T. Tse, J.D. Pendleton, W.M. Beyer, M.C. Egalka, and E.C. Guinan Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 75 2003 389 397
3. K. Le Blanc, L. Tammik, B. Sundberg, S.E. Haynesworth, and O. Ringden Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex Scand. J. Immunol. 57 2003 11 20
4. F. Djouad, P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, D. Noel, and C. Jorgensen Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals Blood 102 2003 3837 3844
5. M. Krampera, S. Glennie, J. Dyson, D. Scott, R. Laylor, E. Simpson, and F. Dazzi Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide Blood 101 2003 3722 3729
6. B. Maitra, E. Szekely, K. Gjini, M.J. Laughlin, J. Dennis, S.E. Haynesworth, and O.N. Koc Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation Bone Marrow Transplant. 33 2004 597 604
7. I. Rasmusson, O. Ringden, B. Sundberg, and K. Le Blanc Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells Transplantation 76 2003 1208 1213
8. J.A. Potian, H. Aviv, N.M. Ponzio, J.S. Harrison, and P. Rameshwar Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens J. Immunol. 171 2003 3426 3434
9. F. Frassoni, M. Labopin, A. Bacigalupo, E. Gluckman, V. Rocha, B. Bruno, H. Lazarus, S. Devine, K. Holland, P. McCarthy, P. Curtin, R. Maziarz, E. Shpall, and A.M. Mosely Expanded mesenchymal stem cells (MSC) co-infused with HLA identical hematopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis Bone Marrow Transplant. 29 2002 S2
10. A. Bartholomew, C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, A. Moseley, and R. Hoffman Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp. Hematol. 30 2002 42 48
11. K. Le Blanc, I. Rasmusson, C. Gotherstrom, C. Seidel, B. Sundberg, M. Sundin, K. Rosendahl, C. Tammik, and O. Ringden Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin- activated lymphocytes Scand. J. Immunol. 60 2004 307 315
12. B.P. Wallner, A.Z. Frey, R. Tizard, R.J. Mattaliano, C. Hession, M.E. Sanders, M.L. Dustin, and T.A. Springer Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein J. Exp. Med. 166 1987 923 932
13. W. Tadmori, J.C. Reed, P.C. Nowell, and M. Kamoun Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies J. Immunol. 134 1985 1709 1716
14. A.M. Krensky, F. Sanchez-Madrid, E. Robbins, J.A. Nagy, T.A. Springer, and S.J. Burakoff The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions J. Immunol. 131 1983 611 616
15. M.K. Majumdar, M. Keane-Moore, D. Buyaner, W.B. Hardy, M.A. Moorman, K.R. McIntosh, and J.D. Mosca Characterization and functionality of cell surface molecules on human mesenchymal stem cells J. Biomed. Sci. 10 2003 228 241
16. K. Yamashita, T. Kakutani, T. Ohashi, and T. Saibara A dimeric form of soluble recombinant sheep LFA-3(CD58) inhibits human T-cell proliferation by generating regulatory T cells Immunopharmacology 37 1997 209 220
17. L.A. Rubin, C.C. Kurman, M.E. Fritz, W.E. Biddison, B. Boutin, R. Yarchoan, and D.L. Nelson Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro J. Immunol. 135 1985 3172 3177
18. D. Degiannis, M. Czarnecki, N. Hornung, J. Raskova, and K. Raska Jr. Mixed lymphocyte reaction-induced release of soluble IL-2 receptor Transplantation 51 1991 518 523
19. D. Degiannis, and N. Hornung Rapamycin inhibits the in vitro release of soluble interleukin-2 receptor by activated peripheral blood mononuclear cells (PBMC) independently of the mode of activation Int. J. Immunopharmacol. 17 1995 593 596
20. M. Uzunel, and O. Ringden Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation Bone Marrow Transplant. 33 2004 47 52
21. M.K. Majumdar, M.A. Thiede, S.E. Haynesworth, S.P. Bruder, and S.L. Gerson Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages J. Hematother. Stem Cell Res. 9 2000 841 848
22. G. Almeida-Porada, C.D. Porada, N. Tran, and E.D. Zanjani Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation Blood 95 2000 3620 3627
23. W.A. Noort, A.B. Kruisselbrink, P.S. in't Anker, M. Kruger, R.L. van Bezooijen, R.A. de Paus, M.H. Heemskerk, C.W. Lowik, J.H. Falkenburg, R. Willemze, and W.E. Fibbe Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice Exp. Hematol. 30 2002 870 878
24. M. Angelopoulou, E. Novelli, J.E. Grove, H.M. Rinder, C. Civin, L. Cheng, and D.S. Krause Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice Exp. Hematol. 31 2003 413 420
25. K. Le Blanc, I. Rasmusson, B. Sundberg, C. Gotherstrom, M. Hassan, M. Uzunel, and O. Ringden Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 2004 1439 1441
26. J. Van Wauwe, J. Goossens, W. Decock, P. Kung, and G. Goldstein Suppression of human T-cell mitogenesis and E-rosette formation by the monoclonal antibody OKT11A Immunology 44 1981 865 871
27. R. Palacios, and O. Martinez-Maza Is the E receptor on human T lymphocytes a "negative signal receptor"? J. Immunol. 129 1982 2479 2485
28. H. Yssel, J.P. Aubry, R. de Waal Malefijt, J.E. de Vries, and H. Spits Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies J. Immunol. 139 1987 2850 2855
29. M. Albert-Wolf, S.C. Meuer, and R. Wallich Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway Int. Immunol. 3 1991 1335 1347
30. C. Gotherstrom, O. Ringden, C. Tammik, E. Zetterberg, M. Westgren, and K. Le Blanc Immunologic properties of human fetal mesenchymal stem cells Am. J. Obstet. Gynecol. 190 2004 239 245
31. P. Merville, C. Lambert, I. Durand, C. Pouteil-Noble, J.L. Touraine, F. Berthoux, and J. Banchereau High frequency of IL-10-secreting CD4+ graft-infiltrating T lymphocytes in promptly rejected kidney allografts Transplantation 59 1995 1113 1119
32. J. Strehlau, M. Pavlakis, M. Lipman, M. Shapiro, L. Vasconcellos, W. Harmon, and T.B. Strom Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation Proc. Natl. Acad. Sci. U. S. A. 94 1997 695 700
33. N.H. Cartwright, A.G. Demaine, N.J. Hurlock, R.J. McGonigle, P.A. Rowe, J.F. Shaw, R.M. Szydlo, and E.R. Kaminski Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching Transplant Immunol. 8 2000 109 114
34. S.G. Danzer, H. Kirchner, and L. Rink Cytokine interactions in human mixed lymphocyte culture Transplantation 57 1994 1638 1642
35. R. Meisel, A. Zibert, M. Laryea, U. Gobel, W. Daubener, and D. Dilloo Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation Blood 103 2004 4619 4621
36. S. Aggarwal, and F. Pittenger Mechanism of human mesenchymal stem cell modulation of allogeneic T cell response Blood 19 2004 (Oct 19) (on line)
37. S. Beyth, Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, H. Aslan, E. Galun, and J. Rachmilewitz Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T cell unresponsiveness Blood 28 2004 (Oct 28) (on line)